metabolic disorders

A unique collection of 540 gut microbial metabolites which can be used for HTS and HCS;

A unique collection of 950 promising or approved mitochondria-targeted compounds including Idebenone, the only approved drug targeting mitochondria, for research in mitochondrial medicine;

1196 glycometabolism-related comounds, can be used for HTS and HCT;

A unique collection of 219 natural products related to gastroenteritis for high throughput screening (HTS) and high content screening (HCS);

1323 compounds derived from heat-clearing and detoxifying TCM for HCS and HTS.

A unique collection of 385 bioactive lipids related compounds for high throughput screening (HTS) and high content screening (HCS), including Agonists & Antagonists, Endocannabinoids, Farnesyl geranylgeranyl derivates, HETEs deHETEs, hepoxilins, Polyunsa

678 hypertension-related small molecules for high-throughput and high-content screening.